Euro high on vaccines

If the vaccine news out of Europe continues to be positive, the Euro may continue to move higher


European vaccines will soon be on the move!  As discussed yesterday in analysis of EUR/GBP, the European Union expects to have a majority of its citizens vaccinated by the end of June,  which ideally could lead to heard immunity sooner than expected for Europe. In addition, although the European Medicines Agency (EMA) found a possible link to very rare cases of unusual blood clots with low blood platelets, they have confirmed that the total benefit-risk remains positive on the AstraZeneca shot. (However, the same time, the UKs medical regulator warned that people aged 18-29 should not use the AstraZeneca vaccine for the same reason).  All of this is good news for the Euro as the currency has been depressed lately vs many currencies on news of lockdowns, restrictions, and the slow vaccine rollout.  Australia and New Zealand have handled the coronavirus situation particularly well. With the positive European vaccine news, the Euro has some catching up to do vs their currencies!

EUR/AUD had been moving lower since October 2020 in an orderly channel formation.  At the beginning of 2020, the pair began making higher lows (holding horizontal support from November 30th, 2018), forming a descending wedge.  In late March, the pair broke above the top downward sloping trendline of the wedge, pulled back to retest the trendline, and today is pushing higher once again.

Source: Tradingview, City Index

On a 240-minute timeframe, EUR/AUD recently broke above a symmetrical triangle and is testing horizontal resistance and the 50% retracement level from the January 29th highs to the February 24th lows, near 1.5600.  The 61.8% Fibonacci retracement level sits just above and acts as then next level of resistance near 1.5683.  Above there, price can run up to the January 29th highs near 1.5947.  However, note that the RSI has moved to overbought territory while price is at resistance on the 240-minute timeframe, indicating the pair may pullback.  Support is back at the top triangle trendline near 1.5550.  Below there is the bottom upward sloping trendline near 1.5455, then the long-term downward sloping trendline (from the daily) and horizontal support near 1.5350.

Source: Tradingview, City Index

A chart of EUR/NZD looks very similar to that of EUR/AUD.  The pair had been moving lower and broke out of a descending wedge on March 23rd. EUR/NZD then traded up to the 38.2% Fibonacci retracement level from the October 20th, 2020 highs to the February 24th lows, near 1.6971.  After a brief pullback, the pair is on the move again and looking to retest those previous highs.   Horizontal resistance above there is near 1.7061 and then the 50% retracement from the same time period , near 1.7134.

Source: Tradingview, City Index

The resistance is similar on the daily and the 240-minute timeframes, however, the support levels are clearer on the shorter timeframe.  As with EUR/AUD, the RSI on the 240-minute chart is near overbought conditions.  The April 5th lows act as first support near 1.6656, followed by the downward sloping trendline near 1.6500, and then the February 24th lows near 1.6323.

Source: Tradingview, City Index

If the vaccine news out of Europe continues to be positive,  the Euro may continue to move higher vs many of its counterparts, as the currency has been so depressed lately.  However, if lockdowns get extended past the end of April or if the vaccine news takes a turn for the worse, the Euro may once again come under pressure.

Learn more about forex trading opportunities.


This report is intended for general circulation only. It should not be construed as a recommendation, or an offer (or solicitation of an offer) to buy or sell any financial products. The information provided does not take into account your specific investment objectives, financial situation or particular needs. Before you act on any recommendation that may be contained in this report, independent advice ought to be sought from a financial adviser regarding the suitability of the investment product, taking into account your specific investment objectives, financial situation or particular needs.

StoneX Financial Pte. Ltd., may distribute reports produced by its respective foreign entities or affiliates within the StoneX group of companies or third parties pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed to a person in Singapore who is not an accredited investor, expert investor or an institutional investor (as defined in the Securities Futures Act), StoneX Financial Pte. Ltd. accepts legal responsibility to such persons for the contents of the report only to the extent required by law. Singapore recipients should contact StoneX Financial Pte. Ltd. at 6826 9988 for matters arising from, or in connection with the report.

In the case of all other recipients of this report, to the extent permitted by applicable laws and regulations neither StoneX Financial Pte. Ltd. nor its associated companies will be responsible or liable for any loss or damage incurred arising out of, or in connection with, any use of the information contained in this report and all such liability is hereby expressly disclaimed. No representation or warranty is made, express or implied, that the content of this report is complete or accurate.

StoneX Financial Pte. Ltd. is not under any obligation to update this report.

Trading CFDs and FX on margin carries a high level of risk that may not be suitable for some investors. Consider your investment objectives, level of experience, financial resources, risk appetite and other relevant circumstances carefully. The possibility exists that you could lose some or all of your investments, including your initial deposits. If in doubt, please seek independent expert advice. Visit for the complete Risk Disclosure Statement.